Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (2) | Back to Search
Biocompatibility of cutaneous formulations containing lipid nanoparticles
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-B-045-Monday
- By: SILVA, Ana (., Porto, Portugal)
- Co-author(s): Ana Silva: UFP Energy, Environment and Health Research Unit (FP-ENAS), Universidade Fernando Pessoa, Porto, Portugal;UCIBIO, ReQuimTe, Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Porto, Portugal
Maria Helena Amaral: Laboratory of Pharmaceutical Technology/Centre of Research in Pharmaceutical Sciences, Faculty of Pharmacy, Porto, Portugal
Filipa Eiras: Laboratory of Pharmaceutical Technology/Centre of Research in Pharmaceutical Sciences, Faculty of Pharmacy, Porto, Portugal
Sara Cunha: Laboratory of Pharmaceutical Technology/Centre of Research in Pharmaceutical Sciences, Faculty of Pharmacy, Porto, Portugal
Renata Silva: Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, Porto, Portugal
Eva Martins: Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, Porto, Portugal
José Sousa Lobo: Laboratory of Pharmaceutical Technology/Centre of Research in Pharmaceutical Sciences, Faculty of Pharmacy, Porto, Portugal - Abstract:
Backgrounds
Lipid nanoparticles (e.g. nanostructured lipid carriers, NLC) have been proposed for cosmetic and dermatological application, by means of semisolid formulations with appropriate consistency. Several studies demonstrated that lipid nanoparticles are safe for therapeutic and cosmetic uses, despite concerns about the potential toxicity of.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023